814 related articles for article (PubMed ID: 27773844)
1. A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans.
Nath S; Ghosh SK; Choudhury Y
J Pharmacol Toxicol Methods; 2017; 84():20-30. PubMed ID: 27773844
[TBL] [Abstract][Full Text] [Related]
2. Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice.
Tahara A; Takasu T; Yokono M; Imamura M; Kurosaki E
Arch Pharm Res; 2016 Feb; 39(2):259-270. PubMed ID: 26450351
[TBL] [Abstract][Full Text] [Related]
3. Improving hepatic mitochondrial biogenesis as a postulated mechanism for the antidiabetic effect of Spirulina platensis in comparison with metformin.
Oriquat GA; Ali MA; Mahmoud SA; Eid RMHM; Hassan R; Kamel MA
Appl Physiol Nutr Metab; 2019 Apr; 44(4):357-364. PubMed ID: 30208279
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model.
Cassano V; Leo A; Tallarico M; Nesci V; Cimellaro A; Fiorentino TV; Citraro R; Hribal ML; De Sarro G; Perticone F; Sesti G; Russo E; Sciacqua A
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32023991
[No Abstract] [Full Text] [Related]
5. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
6. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
[TBL] [Abstract][Full Text] [Related]
7. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
Mokashi P; Bhatt LK; Khanna A; Pandita N
Biomed Pharmacother; 2017 Dec; 96():1427-1437. PubMed ID: 29031588
[TBL] [Abstract][Full Text] [Related]
8. Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamide-induced type 2 diabetic mice.
Tahara A; Matsuyama-Yokono A; Shibasaki M
Eur J Pharmacol; 2011 Mar; 655(1-3):108-16. PubMed ID: 21266174
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-stabilized selenium nanoparticles alleviate cardio-hepatic damage in type 2 diabetes mellitus model via regulation of caspase, Bax/Bcl-2, and Fas/FasL-pathway.
Mohamed AA; Khater SI; Hamed Arisha A; Metwally MMM; Mostafa-Hedeab G; El-Shetry ES
Gene; 2021 Feb; 768():145288. PubMed ID: 33181259
[TBL] [Abstract][Full Text] [Related]
10. ANTI-DIABETIC EFFECTS OF ZHUODUQING FORMULA, A CHINESE HERBAL DECOCTION, ON A RAT MODEL OF TYPE 2 DIABETES.
Feng XT; Tang SY; Jiang YX; Zhao W
Afr J Tradit Complement Altern Med; 2017; 14(3):42-50. PubMed ID: 28480415
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet.
Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
Endocrinology; 2012 Aug; 153(8):3878-85. PubMed ID: 22621958
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the duration of high-fat diet and the dosage of streptozotocin on establishing experimental animal model of type 2 diabetes mellitus].
Wang B; Li Y; Liu X; Liu S; Sun C
Wei Sheng Yan Jiu; 2011 Jan; 40(1):99-102, 106. PubMed ID: 21434325
[TBL] [Abstract][Full Text] [Related]
13. Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats.
Zhang Q; Xiao X; Li M; Yu M; Ping F; Zheng J; Wang T; Wang X
PLoS One; 2017; 12(10):e0184735. PubMed ID: 29036231
[TBL] [Abstract][Full Text] [Related]
14. Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice.
Rhee KJ; Lee CG; Kim SW; Gim DH; Kim HC; Jung BD
Int J Med Sci; 2015; 12(12):987-94. PubMed ID: 26664261
[TBL] [Abstract][Full Text] [Related]
15. Biological function of dipeptidyl peptidase-4 on type 2 diabetes patients and diabetic mice.
Qiao J; Li L; Ma Y; Shi R; Teng M
Curr Res Transl Med; 2019 Aug; 67(3):89-92. PubMed ID: 30591375
[TBL] [Abstract][Full Text] [Related]
16. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
[TBL] [Abstract][Full Text] [Related]
18. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
19. Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Eur J Pharmacol; 2009 Mar; 605(1-3):170-6. PubMed ID: 19171131
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of high fat diet fed and low dose streptozotocin induced diabetic Wistar rat model.
Wickramasinghe ASD; Attanayake AP; Kalansuriya P
J Pharmacol Toxicol Methods; 2022; 113():107144. PubMed ID: 34896263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
